CD79A and pneumonia: In the second case, an elderly patient developed the piperacilin-dependent platelet antibodies and nonpathogenic heparin/PF4 IgA antibodies, which led to the drug-induced thrombocytopenia after pneumonia treatment with piperacilin/tazobactam.